Votubia Drug Insights Market Report 2018 With Forecasts to 2020 - ResearchAndMarkets.com

DUBLIN--()--The "Votubia - Drug Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location.

The report covers the Global Market Assessment of Votubia covering the historical global sales and also provides Votubia sales estimation during the forecasted period (2018-2020). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Votubia and emerging therapies in this space.

Scope:

  • A review of the Votubia, based on information derived from company and industry-specific sources
  • Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
  • Coverage of the Drug Master Files and API Manufacturers by country
  • Patent Expiry Timeline and Exclusivity Details
  • Route of Synthesis of the API
  • Forecasted Sales Figure from 2018-2020
  • Market competition and emerging therapies
  • SWOT Analysis

Reasons to Purchase:

  • Establish a comprehensive understanding of Votubia
  • Access to drug's API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around drug's patents for the major markets - US and EU
  • Understand Votubia's current and future growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for the drug
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug

Key Topics Covered:

  1. Introduction
  2. Votubia - Overview
  3. Product Details
  4. Votubia Sales Assessment
  5. Patent Details
  6. Global API Manufacturers Assessment
  7. Market Competition
  8. Emerging Therapies
  9. SWOT Analysis

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/wl39vm/votubia_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs